Symphony Financial, Ltd. Co. Novartis Ag Transaction History

Symphony Financial, Ltd. Co.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 12, 2021	SELL	$81.78 - $95.14 $343,312 - $399,397	-4,198 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$85.24 - $94.15 $357,837 - $395,241	4,198 New	4,198 $383,000
Q4 2020 Jan 13, 2021	SELL	$78.07 - $94.43 $254,664 - $308,030	-3,262 Closed	0 $0
Q3 2020 Oct 09, 2020	BUY	$82.14 - $91.0 $267,940 - $296,842	3,262 New	3,262 $284,000
Q2 2020 Jul 08, 2020	SELL	$80.93 - $91.1 $267,230 - $300,812	-3,302 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$70.67 - $99.01 $233,352 - $326,931	3,302 New	3,302 $270,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Symphony Financial, Ltd. Co., based on Form 13F filings with the SEC.

Stay updated on Symphony Financial, Ltd. Co. with notifications on news.